HERNEXEOS 60 mg/1
zongertinib · TABLET, FILM COATED · Boehringer Ingelheim Pharmaceuticals, Inc.
HERNEXEOS is a tablet, film coated containing zongertinib at 60 mg/1, taken oral. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Key Facts
- Brand Name
- HERNEXEOS
- Generic Name
- zongertinib
- NDC Code (Product)
0597-9257- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 60 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA219042
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 08/08/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is HERNEXEOS used for?
HERNEXEOS contains zongertinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is HERNEXEOS a controlled substance?
HERNEXEOS is not classified as a controlled substance by the DEA.
What is the generic name for HERNEXEOS?
The generic name for HERNEXEOS is zongertinib. There are no other listed brand versions of zongertinib.
What is the NDC code for HERNEXEOS 60 mg/1?
The NDC (National Drug Code) for HERNEXEOS 60 mg/1 is 0597-9257, listed by Boehringer Ingelheim Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)